Searched for
RIBONUCLEIC ACID
Gene therapy for cholesterol: Initial test results cheerA new gene editing medicine, VERVE-102, offers hope for millions with heart conditions. Eli Lilly's drug showed significant reductions in b...- Good mRNA! A Nobel breakthrough storyImmunologist Drew Weissman and biochemist Katalin Kariko have been awarded the 2023 Nobel Prize in Physiology or Medicine for their discove...
- Cipla to invest 15 million euros in Germany’s Ethris to expand respiratory portfolioThe investment will facilitate a long-term strategic partnership between Cipla and Ethris for development of messenger RNA (mRNA)-based the...
- Biological E to get mRNA technology from WHO to make COVID-19VaccinesWHO along with its partners will work with the Indian government and BE to develop a roadmap and put in place the necessary training and su...
- Researchers from IIT Bombay, UK university develop low-cost sensor that can detect Covid in wastewaterThe sensor was tested with wastewater collected from a sewage treatment plant in Mumbai.
- UK, Indian scientists develop low-cost sensor to detect COVID-19 in wastewaterResearchers from the University of Strathclyde and the Indian Institute of Technology (IIT) Bombay have developed a technology that can be ...
- India's Biological E. to make Providence Therapeutics' mRNA COVID-19 vaccineProvidence will sell up to 30 million doses of its mRNA vaccine, PTX-COVID19-B, to Biological E., and will also provide the necessary techn...
- Wipro partners with Transcell Oncologics to transform vaccine safety assessmentBy applying augmented intelligence to the vaccine development process, the solution can predict adverse neurovirulent impacts resulting fro...
- US buys additional 100 million doses of Moderna vaccineThe agreement brings the total number of Moderna doses bought by the US to 200 million, enough to immunize 100 million people with the two-...
- Moderna vaccine confers at least 3 months immunity, shows studyResearchers at the National Institute for Allergies and Infectious Diseases (NIAID), which co-developed the drug, studied the immune respon...
- EU reviewing Pfizer-BioNTech COVID-19 vaccine in real timePfizer and BioNTech said in a joint statement the start of the review is based on data from laboratory and animal testing, as well as early...
- Hyderabad based Biophore India gets DCGI nod to manufacture COVID drug FavipiravirFavipiravir is an antiviral agent that was initially discovered and developed because of its activity against another RNA (ribonucleic acid...
- COVID-19: Testing, treatment free for Ayushman Bharat beneficiaries at pvt labs, empanelled hospitalsHospitals empanelled under the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) can use their authorised testing facilities or t...
- Packard Foundation offers $875K fellowship to Indian-American biologist Ankur JainThe academician researched about how RNA aggregation contributes to neurological diseases.
- Programming cells like computers to fight diseaseLondon, Sep 18 (IANS) A new technique can help programme cells like a computer to fight cancer, influenza, and other serious conditions, su...
- New method to make lung cancer drug trials more successfulMelbourne, June 14 (IANS) Australian researchers have developed a new method for finding participants in clinical trials of lung cancer dru...
- Chinese scientists discover 1,445 new virusesThe research was led by a team of scientists at the Chinese Centre for Disease Control and Prevention (CDC), with the findings published on...
- How to stop common cold, HIV virus in their tracks foundScientists have cracked the code used by a major group of viruses to spread infections such as the common cold, HIV, hepatitis C and polio ...
- New 'drug' blocks replication of AIDS virus for first timeThis achievement has been obtained for the "first time in the world" by a group of researcher led by Jose Gallego from Universidad Catolica...
- Lab breakthrough opens way to cure for cold soresCold sores, the painful blemishes of the mouth caused by the herpes simplex virus, may become a thing of the past, US researchers reported ...
Load More
